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Cells of the melanocyte lineage are distinguished by their capacity to synthesize
the pigment melanin. Production of melanin is primarily regulated by the enzyme
tyrosinase (monophenol, 3,4-dihydroxyphenylalanine : oxygen oxidoreductase, EC
1.14.18.1), and it is presumed that melanin synthesis can be regulated at a number
of levels that control both the amount ofmelanin synthesized and the type of melanin
produced. Melanin synthesis occurs principally in specialized organelles, the melano-
somes. Thus, the synthesis of melanin is usually restricted to melanocytic cells that
contain melanosomes.
In this report, we describe isolation of a full-length cDNA clone encoding human
tyrosinase by using a probe homologous to the Pmel 34 cDNA sequence described
by Kwon et al. (1). We have transfected and expressed this new human tyrosinase
cDNA clone in mouse fibroblasts, and have induced pigmentation in a cell type that
does not normally synthesize melanin. Levels of tyrosinase activity in transfected
fibroblasts were equivalent to tyrosinase levels in highly pigmented human mela-
noma cell lines. These tyrosinase-positive fibroblast cell lines demonstrate that melanin
synthesis can take place in cells that do not have melanosomes and, therefore, pro-
vide a tool for studying the regulation, transport, and processing of tyrosinase.
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Materials and Methods
Cell Culture and Cell Lines.
￿
Melanoma cell lines were established as previously described
(2). TK- L929 cells(mouse fibroblasts) (3) were used for transfection experiments. Cell lines
were maintained in Eagle's MEM supplemented with 2 mM glutamine, 0.1 mM nonessential
amino acids (aa)', 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 10% FCS (complete
medium). Cells were passaged with trypsin (1 mg/ml) and EDTA (0.2 mg/ml). All cultures
were checked regularly for the presence ofmycoplasmaand contaminated cultures were dis-
carded.
EM.
￿
Cell pellets were fixed in Karnofsky's fixative overnight, rinsed in PBS for 1 h, and
then post-fixed for 1 h in 1% osmium tetroxide-PBS solution. Cell pellets were dehydrated
in graded ethyl alcohol followed by propylene oxide, and embedded in Maraglas-D.E.R. 732
epoxy resin (Dow Corning Corp., Midland, MI). For orientation, 1-lAm thick sections were
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stained with borate-buffered 1% toluidine blue. Thin sections were stained with uranyl ace-
tate followed by lead citrate and were examined with an electron microscope (410 LS; Phillips
Electronic Instruments, Inc., Mahwah, NJ).
cDNA Library and Screening.
￿
A cDNA library was constructed from 3 gg of poly(A)'
selected mRNA (4) prepared from the human melanotic melanoma cell line SK-MEL-19 (2).
Full-length cDNA was synthesized, rendered blunt ended using Klenow enyzme, and tailed with
Eco RI linkers (New England Biolabs, Inc., Beverly, MA) (5). The cDNA was then size fraction-
ated on Ultrogel Aca 34 (Pharmacia Fine Chemicals, Piscataway, NJ) (6). cDNA molecules
>800 by were used to construct a library of 3 x 105 recombinants in the X phage vector gt10
(7). For screening, a 50-base oligonucleotide probe (50-mer, shown below) based on the 5'
terminal coding region of the human tyrosinase Pmel 34 cDNA clone (1) was used: 5'
GTTCTTAGAGGAGACACAGGCTCTAGGGAAAATGGCCAGCGGAGGTCTGGA3'.
The oligonucleotide was synthesized on a DNA synthesizer (310 A; Applied Biosystems,
Inc., Foster City, CA). The probe was end labeled with -y-[32P]ATP and T4 polynucleotide
kinase (4). Prehybridization and hybridization were carried out at 48°C for 4 and 18 h, respec-
tively, in 6 x NaCI/EDTA/Tris (NET) (1 x NET is 0.15 M NaCl, 1 mM EDTA, and 15 mM
Tris-HCI, pH 8), 0.1% SDS, and 5 x Denhardt's solution (0.1% BSA, 0.1% Ficoll 400, 0.1%
polyvinylpyrrolidone), and 100 p,g/ml of denatured salmon sperm DNA. Duplicate filters
were washed in 6 x NET, 0.1 % SDS at room temperature, followed by stringent washes at
55°C and 60°C. The filters were then autoradiographed for 4 h at -70°C .
DNA Sequencing.
￿
Plaque-purified phage DNA was restricted with Eco RI, and cDNA in-
sertswere subcloned into the plasmid-vector pUC 18 (8). Recombinant plasmids and deletion
subclones subsequently obtained by digestion with exonuclease III/Mung Bean nuclease (9)
were sequenced by the dideoxynucleotide chain termination method (10).
Northern Blot Analysis.
￿
Poly (A)'-mRNA (4 Wg) was fractionated on 1% formaldehyde de-
naturing agarose gels (4), transferred to Gene Screen Plus membranes (New England Nu-
clear, Boston, MA), and hybridized to a 32P-labeled cDNA probe. The filters were washed
twice at room temperature in 2 x SSC (1 x SSC is 0.15 M NaCl, 0.015 M sodium citrate,
pH 7) and 1% SDS, then,stringent washes were carried out at 55'C in 1 x SSC, 1% SDS,
and at 65'C in 0.1 x SSC, 1% SDS, for 15 min each.
Transfection Experiments.
￿
The cDNA inserts were subcloned into the Eco RI site of the ex-
pression vector pcEXV3, which allows expression of cDNA under the control of SV40 early
region promoter and enhancer sequences (11). Expression plasmids containing cDNA inserts
in opposite orientations (5'-3'or 3'-"5') were constructed. Sense and antisense oriented plasmids
were designated pcTYR and peTYW, respectively. L929 cells were cotransfected by the cal-
cium phosphate precipitatiomtechnique (12) with pUC 18, pcTYW or pcTYR, the PSV2 neo
plasmid, and high molecularweight carrier DNA from L929 cells. Selection of transfectants
was started on day 3 after ttansfection with 1 mg/ml of the antibiotic G418 (Sigma Chemical
Co., St. Louis, MO):C'o`mplete medium with G418 was replaced every 3 d, and colonies ap-
pearing;on days 1014 were isolated using cloning rings and were then expanded. The mouse
origin of-transfected cell lineswas confirmed by positive anti-mouse Ig mixed hemadsorption
assays using=H100-5R28, an mAb directed against H-2Kk (mouse MHC class I antigens)
(13), and lack of reactivity with mAb M3-68 (14) or AJ2 (15), which recognize virtually all
human melanoma cells but not L929 cells (data not shown).
SerologicalReagents andAssays.
￿
CF21 (IgGI) and TA99 (IgG2a) are mAbs, which have been
previously described (16), that recognize distinct antigens in human melanosomes. The mAb
2G10 (IgG2a) (17) was a generous gift from Dr. P G. Natali, (Regina ElenaCancer Instituto,
Rome, Italy). This antibody recognizes a 75-kD intracellular glycoprotein ofpigmented mela-
notic cells (17). mAb AJ2 (IgGI) recognizes the R subunit of human integrin molecules (15,
18). Rabbit antityrosinase antiserum was raised by immunization with purified mouse
tyrosinase (19). Briefly, tyrosinase was purified by DEAE ion exchange chromatography fol-
lowed by sequential discontinuous PAGE. The anti-mouse Ig hemadsorption assays and the
indirect immunofluorescence studies were performed as described (2, 20).
Immunoprecipitations.
￿
Cells were labeled with 35S-methionine (ICN Radiochemicals, Ir-
vine, CA) for 16 h in methionine-free complete medium containing 2% dialyzed FCS, and
lysed in 50 mM Tris, 5 mM EDTA, 0.5% NP-40, 1 mM PMSE The lysates were preclearedBOUCHARD ET AL.
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twice by incubation with 5 Wg/ml of protein A-Sepharose (Pharmacia Fine Chemicals) for
30 min at 4°C. Immunoprecipitations were performed by incubating the lysates with anti-
bodies, followed by addition of protein A-Sepharose. The immunoprecipitates were exten-
sively washed and analyzed for molecular size by SDSIPAGE (21) under reducing conditions.
Tyrosinase Activity and Melanin Assays.
￿
Cells were solubilized in PBS, I% NP-40, pH 6.8,
and centrifuged to obtain clear supernatants. Tyrosine hydroxylase activity was assayed using
a modification ofthe method described by Pomerantz (22). Briefly, the reaction mixture con-
tained 1 ACi/ml [3H]tyrosine (54.2 Ci/mMol) in PBS, 1% NP-40, 0.1 MM L-tyrosine, and
0.1 MM L-dihydroxyphenylalanine (L-DOPA). The reaction was carried out at 37°C for 1 h,
and terminated by addition of 0.2 ml of a charcoal suspension (100 mg/ml in 0.1 M citric
acid). After 30 min on ice, the samples were centrifuged and an aliquot was counted in a
scintillation counter (LS 9000; Beckman Instruments, Inc., Fullerton, CA). All assays were
performed in duplicate. Controls included 3H20 release measured in lysates from the human
renal carcinoma cell line SK-RC-7 and reaction mixture in PBS, 1% NP-40 alone. Specific
tyrosinase activity was calculated as follows: (3H20 release by test cell lysate) - (3H20 re-
lease by control reaction mixture in PBS). Protein concentrations were determined by the
Bradford's dye binding method using the Protein Assay Kit (Bio-Rad Laboratories, Rich-
mond, CA). For melanin assays, 3 x 106 cells were solubilized in 0.5 ml Protosol (New En-
gland Nuclear) and kept on ice for 2 h. An absorption baseline was established using Pro-
tosol, and absorption spectra for cell extracts were determined between 320 and 450 nm and
compared against a melanin control, 100 ftg/ml, in Protosol.
Results
Isolation andSequencing ofthecDNA Clone BBTY-1.
￿
cDNA clones were isolated from
a X gtl0 library derived from the pigmented human melanoma cell line SK-MEL-19
(see Materials and Methods). 105 recombinant cDNA clones were screened and four
reactive clones were plaque purified. The four cDNA inserts were subcloned into
the plasmid vector pUC 18 and clones were designated pBBTY1, -2, -3, and -4.
Two clones, pBBTYl and pBBTY2, each containing cDNA inserts of 2 kb, had
restriction maps identical to each other and to that of Pmel 34, reported by Kwon
et al. (1) (digested with Bgl II, Hpa II, Msp I, Nco I, Pvu II, and Taq I). The cDNA
inserts in clones pBBTY3 and pBBTY-4 were 1.7 and 1.8 kb, respectively. The re-
striction map ofpBBTY3 was different from those ofpBBTYl and pBBTY2 down-
stream ofposition 960 (a Pvu II restriction site). pBBTYl was subsequently sequenced
and used for further experiments.
The nucleotide sequence of BBTY1 (Fig. 1) contained a single open reading frame
of 1,593 residues capable of encoding a 531-aa polypeptide with a derived molecular
mass of 60.37 kD. A leader peptide of 19 as was assigned to positions -19 through
-1 (23). The processed core protein was predicted to have a molecular mass of 58.11
kD. Seven potential N-glycosylation signals (Asn-X-Ser/Thr) were predicted at posi-
tions 69, 94, 144, 213, 273, 320, and 354. Based on a hydrophobicity plot, according
to the method of Kyte and Doolittle (24), a transmembrane region was predicted
within a highly hydrophobic domain between as positions 470 and 490. There was
a 318 base 3' noncoding region that contained an atypical polyadenylation signal,
AATTAAA (25). The nucleotide and as sequences of BBTY1 were nearly identical
to the sequence of the Pmel 34 cDNA. (1). However, BBTY1 contained an addi-
tional upstream 5' sequence, including a potential initiation codon not present in
Pmel 34 (bases 1-7). There were also differences in the predicted as sequence of
BBTY1 at positions 25-28, 162, 291, 356-361, 385, 478, and 503-512. The predicted
molecular size ofthe processed protein coded by BBTY1 was smaller than the processed2032
￿
EXPRESSION OF HUMAN TYROSINASE IN MOUSE FIBROBLASTS
-1 W 1
-19 Gly Arg Met Leu Leu Ale Vat Leu Tyr Cys Leu Lou Trp Ser Phe Gin Thr Ser Ale Gly
1 GGA AGII ATG CTC CTG GCT GTT TTG TAC TGC CTG CTG TGG AGT TIC LAG ACC TCC GCT GGC
2 His Phe Pro Arg Ala Cys Vat Ser Ser Lys Asn
Lou
Met Glu Lys Glu Cys Cys Pro Pro
61 CAT TIC CCT AGA GCC TGT GTC TCC TCT AAG AAC CTG ATG GAG AAG GAA TGC TGT CCA CCG
22 Trp Ser Gly Asp Arg Ser Pro Cys Gty Gin Lou Ser Gly Arg Gty Ser Cys Gin Asn Ile
121
￿
TGG AGC GGG WC AGG AGT CCC TGT GGC CAC CTT TCA GGC AGA GGT TCC TGT CAG AAT ATC
42 Lou Leu Ser Asn ALA Pro Lau Gly Pro Gin Phe Pro Phe Thr Gly Vat Asp Asp Arg Giu
181 CTT CTG TCC AAT GCA CCA CTT GGG CCT CAA TTT CCC TIC ACA GGG GTG GAT Glit CGG GAG
62 Ser Trp Pro Ser Vat
Pi's
Tyr Asn Arg Thr Cys Gin Cys Ser Gly Asn Phe Net Gly Phe
241 TCG TGG CCT TCC GTC TTT TAT AAT AGG ACC TGC CAC TGC TCT GGC AAC TYC ATG GGA TIC
82 Asn Cys Gly Aan Cys Lys Phe Gly Phe Trp Gty Pro Asn Cys Thr Glu Arg Arg Leu
Lou
301 AAC TGT GGA AAC TGC AAG TTT GGC TTT TGG GGA CCA AAC TGC ACA GAG AGA CGA CTC TTG
102
￿
Vat Arg Arg Asn I Is Phe Asp Leu Ser Ale Pro Glu Lys Asp Lys Phe Phe Ala Tyr
Lou
361
￿
GTG AGA AGA AAC ATC TTC GA T TTG AGT GCC CCA GAG AAG GAC AAA TTT
TIT
GCC TAC CTC
122
￿
Thr Leu Ale Lys His Thr Iis Ser Ser Asp Tyr Vat
￿
ILe Pro I Is Gty Thr Tyr Gly Gin
421 ACT TTA GCA AAG CAT ACC ATC AGC TCA GAC TAT GTC A7C CCC ATA GGG ACC TAT GGC CAA
142
￿
Net Lys Asn Gly Ser Thr Pro Met Phe Asn Asp I to Asn ILe Tyr Asp
Lou
Phe Vat Trp
481 ATG AAA AAT GGA TCA ACA CCC ATG TTT AAC GAC ATC AAT ATT TAT GAC CTC TTT GTC TGG
162 Its His Tyr Tyr Vat Ser Met Asp Ale Leu Leu Gty Gly Tyr GLu lie Trp Arg Asp lie
541 ATC CAT TAT TAT GTG TCA ATG GAT GCA CTG CTT GGG GGA TAT GAA ATC TGG AGA GAC ATT
182 Asp Phe Ate His Glu Ala Pro Ala Phe Lou Pro Trp His Arg Lou Phe Lou
Lou Arg 7rp
601 GAT TIT GCC CAT GAA GCA CCA GCT TTT CTG CCT TGG CAT AGA CTC
ITC
TTG TTG CGG TGG
202 Glu Gin GLu Its Gin Lys Leu Thr Gly Asp Glu Asn Phe Thr lie Pro Tyr Trp Asp Trp
661 GALA CAA GAA ATC CAG AAG CTG ACA GGA GAT GAA AAC TIC ACT ATT CCA TAT TGG GAC TGG
222 Arg Asp ALa,GIu Lys Cys Asp lie Cys Thr Asp Glu Tyr Met Gly Gty Gin His Pro Thr
721 CGG GAT GCA GAA AAG TGT GAC ATT TGC ACA GAT GAG TAC ATG GGA GGT CAG CAC CCC ACA
242 Asn Pro Asn
Lou Lou
Ser Pro Ale Ser Phe Phe Ser Ser Trp Gin Ile Vat Cys Ser Arg
781
￿
AA7 CCT AAC TTA CTC AGC CCA GCA TCA TTC TIC TCC TCT TGG CAG ATT GTC TGT AGC CGA
262 Leu Glu Giu Tyr Asn Ser His Gin Ser Leu Cys Asn Gly Thr Pro Glu Gly Pro Leu Arg
841 TTG GAG GAG TAC AAC AGC CAT CAG TCT TTA TGC AAT GGA ACG CCC GAG GGA CCT TTA CGG
282 Arg Asn Pro Gly Asn His Asp Lys Ser Arg Thr Pro Arg Lou Pro Ser Ser Ala Asp Vat
901 CGT AAT CCT GGA AAC CAT GIIC AAA TCC AGA ACC CCA AGG CTC CCC TCT TCA GCT GAT GTA
302 Glu Phe Cys Leu Ser Leu Thr Gin Tyr Glu Ser Gly Ser Met Asp Lys Ale Ala Asn Phe
961 GAA TIT TGC CTG AGT TTG ACC CAA TAT GAA TCT GGT TCC ATG GAT AAA GCT GCC AAT TIC
322 Ser Phe Arg Asn Thr Leu Gtu Gly Phe Ala Ser Pro Lou Thr GLy Ile Ala Asp Ala Ser
1021 AGC TTT AGA AAT ACA CTG GAA GGA TTT GCT AGT CCA CTT ACT GGG ATA GCG GAT GCC TCT
342 Gin Ser Ser Met His Asn Ale Lou His Ile Tyr Met Asn Gly Thr Met Ser Gin Vat Gin
1081 CAA AGC AGC ATG CAC AAT GCC TTG CAC ATC TAT ATG AAT GGA ACA ATG TCC CAG GTA CAG
362 Giy Ser Ale Asn Asp Pro lie Phe Leu Leu His His Ala Phe Vat Asp Ser Ile Phe Glu
1141 GGII TCT GCC AAC GAT CCT ATC TIC CTT CTT CAC CAT GCA TTT GTT GAC AGT ATT TTT GAG
382 Gin Trp Lou Arg Arg His Arg Pro Leu Gin Glu Vat Tyr Pro Glu Ala Asn Ala Pro lie
1201 CIIG TGG CTC CCdA AGG CAC CGT CCT CTT CAA GAA GTT TAT CCA GAA GCC AAT GCA CCC ATT
402 Gty His Asn Arg Glu Ser Tyr Met Vat Pro Phe lie Pro Leu Tyr Arg Asn Gty Asp Phe
1261 GGA CAT AAC CGG GAA TCC TAC ATG GTT CCT TTT ATA CCA CTG TAC AGA AAT GGT GAT TIC
422
Pi's
lie Ser Ser Lys Asp Leu GIy Tyr Asp Tyr Ser Tyr Leu Gin Asp Ser Asp Pro Asp
1321 TIT ATT TCA TCC AAA GAT CTG GGC TAT GAL TAT AGC TAT CIA CAA GAT TCA GAC CCA GAC
442 Ser Phe Gin Asp Tyr Ile Lys Ser Tyr Lou Glu Gin Ala Ser Ark; lie Trp Ser Trp Lou
1381 TCT
TIT
CAA GAC TAC ATT AAG TCC TAT TTG GAA CAA GCG AGT CGG ATC TGG TCA TGG CTC
462 Lou Gly Ala Ate Met Vat Gly Ale Vat
Lou
Thr Ala Leu Lou Ala Gly Leu Vat Ser Leu
1441 CTT GGG GCG GCG ATG GTA GGG GCC GTC CTC ACT GCC CTG CTG GCA GGG CTT GIG ACC TTG
482 Lou Cys Arg His Lys Arg Lys Gin
Lou Pro Glu Glu Lys Gin Pro Lou Lou Met Gtu Lys
1501 CTG TGT CGT CAC AAG AGA AAG CIIG CTT CCT GAA GAA AAG CAG CCA CTC CTC ATG GAG AAA
502 Gtu Asp Tyr His Ser Lou Tyr Gin Ser His Leu
1561 GAG GAT TAC CAC AGC TTG TAT CAG AGC CAT TTA TAAAAGGCTTAGGCAATAGAGTAGGGCCAAAAAGC
1628 CTGACCTCACTCTAACTCAAAGTAATGTCCAGGTTCCCAGAGAATATCTGCTGGTATTTTTCTGTAAAGACCATTTGCA
1707 AAATTGTAACCTAATACAAAGTGTAGCCTTCTTCCAACTCAGGTAGAACACACCTGTCTTTGTCTTGCTGTTTTCACTC
1786 AGCCCTTTTAACATTTTCCCCTAAGCCCATATGTCTAAGGAAAGGATGCTATTTGGTAATGAGGAACTGTTATTTGTAT
1865 GTGAATTAAAGTGCTCTTATTTTAAAAAA
FIGURE 1.
￿
Nucleotide and predicted amino acid sequence of BBTY-1 cDNA. The nucleotide
sequence is numbered in the5' to 3' direction. Residues ofapredictedsignal peptide are indicated
by negative numbers, anda cleavage site by avertical arrow. Termination site (TAA) and polyad-
enylationsignal (1869-1875) areunderlined. Potentialglycosylation sites aredesignatedby dashed
lines. These sequence data have been submitted to the EMBL/GenBank Data Libraries under
the accession number Y00819.BOUCHARD ET AL .
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protein predicted from Pme134 (62 .16 kD). Based on this sequence analysis, BBTY-
1 wasacandidate for a full-lengthcDNA cloneencompassing acomplete coding region.
Transcription ofBBTY-1 in Human Melanoma Cells. BBTY1 cDNA was used to de-
tect mRNA transcripts in Northern blot analysis of a panel ofmelanoma cell lines,
including those known to express tyrosinase activity as well as tyrosinase-negative
melanomas. The majortranscript detected was 2.4 kb, but aweaker signal was seen
at 4.7 kb (Fig . 2) . Three groups of melanomas were observed based on Northern
blot analysis using poly (A)'-selected RNA (data not shown) . (a) mRNA was de-
tected in nine pigmented melanomas that expresstyrosinase activity; (b) nomRNA
was detected in five nonpigmented, tyrosinase-negative melanomas ; and (c)mRNA
was detected in three nonpigmented, tyrosinase-negative melanomas . Therewas little
or no difference in the intensity ofmRNA signal detected in groupcvs . a . No tran-
script was detected in mRNA from the B cell lymphoma cell line Daudi or from
the T cell leukemia cell line HUT78 .
Melanin Synthesis in L929 Cells Transfected with BBTY-1 .
￿
BBTY-1 was transfected
into L929 mouse fibroblasts using the expression vector pcEXV3 (11) . L929 cells
transfected with pcTYR (sense orientation) were designated LpcTYR . Control cells
transfectedwithpcTYW (antisense orientation) were designated LpcTYW, and, with
the plasmidpUC 18, were designated LpC . LpcTYR cells contained pigment, while
no pigmentation was detected in LpcTYW, LpC, or untransfected L929 cells . As
shown in Fig. 3, the cell pellets ofLpcTYR clones were dark brown in contrast to
the nonpigmented pellets of LpcTYW and LpC cultures .
Cell pellets ofLpcTYR were more deeply pigmentedwhen cultures were harvested
at confluency. LpcTYR clones have continued to produce pigment for>5 mo in con-
tinuous culture. To confirm that the pigment in LpcTYR has the characteristics of
melanin, absorption spectra of cell extracts from LpcTYR and control L929 cells
were compared with those ofextracts ofthepigmentedmelanoma cell lineSK-MEL-19
andpurified melanin . LpcTYR and SK-MEL-19 extractsand melanin had identical
patterns of absorption, with broad absorption from 360 to >450 nm ; this absorption
pattern was not observed with L929 cell extracts (data not shown) . The absorption
patterns by extracts ofLpcTYR and SK-MEL-19 and melanin standard were iden-
tical to the previously described absorption spectra for melanin (26) .
-28s
-18S
FIGURE 2 .
￿
Northern blot analysis of poly (A) +-selected RNA (4 ug/
lane) from two pigmented melanoma cell lines that express tyrosinase
and the B cell lymphoma cell line Daudi . The blotCvas hybridized with
the 12p-labeled insert of pBBTY-1 . Lanes 1, SK-MEL-23 melanoma ; lane
2, SK-MEL-19 melanoma; lane 3, Daudi .2034
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FIGURE 3 .
￿
Cell pellets ofL929 cells transfected with senseBBTY-l (LpcTYR cell line), antisense
BBTYl (LpcTYW cell line), or pUC 18 plasmid (LpC cell line) . LpcTYR and LpcTYW cell
lines were transfected with BBTY1-inserted sense or antisense intothe expression vector pcEXV3 .
LpcTYR-1 and LpcTYR-2 are subclones of LpcTYR . (1) LpC cell pellet (nonpigmented) ; (2)
LpcTYW (nonpigmented) ; (3) LpcTYR l (pigmented) ; and (4) LpcTYR-2 (pigmented) .
Small clusters of cell containing dark cytoplasmic inclusions were observed
throughout the LpcTYR culture by light microscopy (Fig . 4) . These clusters of cells
always comprised a minority ofthe culture population . Occasional blackround cells
were detected floating in the tissue culture medium, perhaps related to cytostatic
or cytotoxic effects of melanin by-products, and the prevalence of these cells increased
as the culture reached confluency . Transmission EM revealed that LpcTYR cells,
but not control LpC cells, had cytoplasmic membrane-bound vesicles (Fig . 5) con-
taining electron-dense material consistent with melanin . There was no evidence of
melanosomal structural elements within LpcTYR cells or LpC cells .
Tyrosinase Activity in L929 Cells Expressing BBTY-1 .
￿
To confirm that the BBTY1
product was human tyrosinase, tyrosine hydroxylase activity was measured in pro-
tein extracts of subclones ofLpcTYR, LpcTYW, and LpC . Cell extracts from two
subclones of LpcTYR, designated LpcTYR1 and LpcTYR2, expressed levels of
tyrosinase activity that were comparable with levels in the pigmented human mela-
noma cell line SK-MEL-19 (Fig. 6) . In contrast, extracts ofLpcTYW and LpC con-
tained no detectable tyrosinase activity.
Analysis ofExpression ofMelanosomal Antigens in LpcTYR Cells.
￿
LpcTYR2, SK-MEL-
19 melanoma cells, and control L929 cells were metabolically labeled with 35S-me-
thionine and cell extracts were immunoprecipitated with rabbit antityrosinase anti-
serum or mAb TA99 (which detects the melanosomal antigen gp75) . In addition,BOUCHARD ET AL .
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FIGURE 4 .
￿
LpcTYR cells in culture . A nest of cells in the middle of the field contains large,
pigmented cytoplasmic granules . (020) .
mAb 2G10 (fromDr. Pier Natali, Regina Elena Instituto, Rome), which is also directed
againstan intracellular75-kD antigen expressedby pigmentedmelanoma cells (17), was
tested . Antityrosinase antiserum detected a 75-kD protein in LpcTYR2 cells and a
protein of the same size in SK-MEL-19 melanoma cells (Fig . 7) . The molecular size
FIGURE 5 .
￿
Transmission electron micrographs of segments of LpcTYR cells . (A) Cytoplasmic
membrane-bound vesicles containingelectron-dense material are indicated by arrows . One scale
bar represents 1 Am . (x8,400). (B) Higher magnification field ofa cytoplasmic membrane-bound
vesicle containing pigment. One scale bar represents 1 Am . (x 16,800) .2036
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FIGURE 6 .
￿
Expression of tyrosi-
nase activity in cell extracts from :
SK-MEL 19 melanoma; Lpc cells
(transfected withpUC 18 plasmid) ;
LpcTYR1 cells (transfected with a
BBTYl sense construct) ; LpcTYR-
2 cells (transfected with a BBTY 1
sense construct) ; andLpcTYW cells
(transfected with a BBTY-1 anti-
sense construct) . Tyrosine hydrox-
ylase activity is expressed as cpm
3H20/min/mg protein(0)or cpm
3H20/min/5 x 10 6 cells (0) .
FIGURE 7 .
￿
Immunoprecipita-
tion of lysates from 35S-me-
thionine metabolically labeled
SK-MEL-19 melanoma cells,
LpcTYR2 cells expressing
BBTY 1, and L929 cells . Lane
1, mAb TA99 ; lane 2, mAb
2G10 ; lane 3, control rabbit
sera; and lane 4, rabbit anti-
tyrosinase antisera. A 75-kD
band is detected in SK-MEL-
19 (with TA99, 2G10, and anti-
tyrosinase) and LpcTYR2 cells
(with antityrosinase) . Molec-
ular weight standards : Myosin
M chain (200 kD) ; phosphory-
lase (96kD) ; BSA(68 kD) ; and
OVA (43 kD) .
of tyrosinase in LpcTYR2 and SK-MEL-19 cells corresponded to the size of gly-
cosylated tyrosinase . A very faint band at -75 kD was inconsistently detected in
L929 cells with antityrosinase antiserum ; this likely represents a crossreaction of
polyclonal sera toanontyrosinase molecule in L929 cells, sinceno tyrosinase activity
or tyrosinase transcript was detected in these cells and cold lysates from L929 cells
did not block immunoprecipitation oftyrosinase from LpcTYR-2 (datanot shown) .
No specific bands were detected by either mAbTA99 or mAb 2G10 in LpcTYR2
extracts, although both antibodies precipitated abroad 75-kDbandfrommelanoma
SK-MEL-191ysates. These results were confirmed usingimmunofluorescence assays .
NeithermAbTA99 nor2G10 stainedLpcTYR cells butboth reacted with SK-MEL-19
cells (Fig. 8) . In addition, mAb CF21, directed against a melanosomal antigen of
unknownmolecular size, did not react with LpcTYR but stained SK-MEL-19 (Fig.
8) . We conclude that mAbs TA99, CF21, and 2G10 identify antigens distinct from
tyrosinase encoded by the BBTY 1 cDNA clone .A
9
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FIGURE 8.
￿
Indirect immunofluores-
cence assays forantigen expression by:
(A)LpcTYR2 cellsexpressingBBTY1;
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and (B) SK-MEL-19 melanoma cells.
mAb TA99 (anti-gp75) (A); mAb
CF21 (antimelanosomal antigen)(*);
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Discussion
Tyrosinase catalyzes the o hydroxylation of monophenols and oxidation of o-di-
phenols to o-quinones. In melanocytic cells, tyrosinase enzymaticallyconverts tyro-
sine to DOPA, and DOPA to dopaquinone, leading to the spontaneous formation
of the complex mixture of pigments known as melanin (27). The later steps in this
pathway arenot well characterized, andit has been suggestedthat anumber ofother
factors, both catalyticand inhibitory, may regulate melanin synthesis and influence
the species of melanin formed (28, 29). The complexity of pigment expression has
been further highlighted by genetic studies in the mouse where >50 loci have been
found to influence coat color(30). Thus, it is possible that a number of gene prod-
ucts, most not yet identified, can play a role in melanogenesis.
It is remarkable that transfected L929 fibroblasts notonly stably expressedtyrosinase
activity but were able to produce and package melanin. Melaninprecursors arecyto-
toxic, and it hasbeen presumed that melanocytic cellscontain mechanisms, perhaps
located within melanosomes, that protect from the effects of toxic intermediates.
We suspect that melanin precursors were in fact cytotoxic in transfected L929 cells,
andthat cellsproducing substantial amounts ofpigment were destined to die, based
on thefollowingobservations: (a) only asubpopulation of transfected cells contained
pigmented vesicles; (b) deeply pigmented, nonviable cells were observed floating in
the supernatant of transfectant cultures; and (c) when transfected cells were cryo-
preserved and then thawed, pigmented cells were not initially detected but eventu-
ally repopulated the culture.2038
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We have not yet analyzed in detail thesynthesis or processing ofhuman tyrosinase
in transfected L929 cells. From our preliminary studies, it appears that human
tyrosinase is glycosylated to a form that is identicalin size to fully processed tyrosinase
expressedin humanmelanocytic cells. It is likely that human tyrosinase wasprocessed
throughthe Golgiapparatusin L929 cellsand transported to or remained in vesicles
arising from the traps-Golgi. Thenature anddestination of thesevesicles is notknown.
It is interesting to speculate that these vesicles might be precursors of melanosomes
but that formation of melanosomes would depend on the products of other special-
ized genes.
The expression and regulation of tyrosinase has been the subject of extensive
studies, but the formal identification of the gene that codes for tyrosinase has not
been straightforward (reviewed in reference31). Twodistinct, and only distantly related,
genes have been proposed as candidates for mouse tyrosinase, based on detection
of mRNA of these genes in melanocytic cells and reactivity of the protein product
with antibodies against tyrosinase (32, 33). Neither gene, however, wasdemonstrated
directly to code for a product with tyrosinase activity. It is likely that antibodies
used to detect the products of putative tyrosinase cDNA clones reacted with other
molecules that copurified with tyrosinase. This situation was recently clarified by
the identification of the mouse tyrosinase gene by Miiller et al. (34) who isolated
a cDNA clone, pmctyri, that coded for transient expression of tyrosinase activity
in transfection assays. No pigment synthesis was reported in transfected cells, pos-
sibly because assays were performed only shortly after transfection, because the re-
cipient cells were different (an amelanotic melanoma and a breast carcinoma cell
line), or becauselevels of tyrosinase activity appeared to be much lowerthan in mouse
fibroblasts transfected with BBTY1.
The candidate forthehumantyrosinase gene, designated Pmel 34, has been reported
by Kwon et al. (1). Kwon et al. (35) also recently described a mousecDNA, MTY811C,
isolated using Pmel 34. The gene product encoded by MTY811C was predicted to
be 81% homologous to the protein encoded by Pmel 34 . Both the human Pmel 34
and themouse MTY811C correspond to thehumancounterpartofthemousepmctyrl
gene, and in fact, the pmctyrl clone was also isolated by screening a cDNA library
from mouse melanoma cells with the Pmel 34 cDNA. The Pmel 34 cDNA clone
was detected by screening a cDNA library with polyclonal antisera raised against
hamster tyrosinase. Pmel 34 has been mapped to the c (albino) locus in the mouse,
the presumed site ofthe tyrosinase structural gene or agene that regulates tyrosinase
expression. The nucleotide and predicted as sequences of BBTY1 and Pmel 34 are
nearly identical. BBTY1 contains an initiation codon that is not present in Pmel
34, and there are minor differences in nucleotide and predicted as sequences. It
is possible that some of these differences represent genetic polymorphism or somatic
mutations (related to the source of cell types used to isolate cDNA, i.e., melanoma
cells for BBTY1 vs. melanocytes for Pmel 34). It is interesting to note that where
there are distinct differences in sequences between BBTY1 and Pmel 34, the se-
quence ofBBTY1 is very close or identical to themousepmctyrltyrosinase sequence
(e.g., as 356-361 and 385).
Multiple transcripts of the tyrosinase gene have been found in mouse melanoma
cells (36) . The remaining transcripts are generated by alternative splicing leading
to deletion of internal sequences, presumably by exon skipping or by selection ofBOUCHARD ET AL.
￿
2039
internal splice sites. When these alternative transcripts have been expressed, they
have notbeen found to encode active tyrosinase (34, 36). The BBTY1 cDNA represents
the human counterpart of the mouse pmctyrl transcript. AnothercDNA clone that
we isolated, BBTY3, differs from BBTY1 in its 3' restriction map, possibly corre-
sponding to an alternative transcript of the human tyrosinase gene.
We have asked what is the relationship of tyrosinase to the melanosomal/cyto-
plasmic antigens recognized by mAbs 2G10, TA99, and CF21 . It has been shown
that mAb2G10 immunodepletes tyrosinase activity (37) and, therefore, possibly recog-
nizes a molecule with tyrosinase activity. However, mAb 2G10 did not react with
human tyrosinase encoded by BBTY-1, suggesting that mAb 2G10 recognizes a dis-
tinct molecule from the gene product of BBTY-1 . TA99 mAb recognizes an acidic
75-kD glycoprotein (38), and the antigen recognized by TA99 is a candidate for
tyrosinase, based on its expression in melanosomes, its molecular size, and charge.
The finding that mAbs TA99 and CF21 did not react with L929 transfectants pro-
vides evidence that they do not recognize determinants coded for by the BBTY-1
human tyrosinase molecule. Further data suggest that mAb TA99 does not recog-
nize tyrosinase: (a) mAb TA99 does not precipitate tyrosinase activity from mela-
noma cell extracts (39, 40); (b) the TA99 antigen, gp75, is generally coexpressed
with tyrosinase activity, but there are examples of gp75+ melanoma cell lines that
do not express tyrosinase activity; and (c) we have been able to regulate indepen-
dently the expression of tyrosinase and gp75 in melanoma cell lines (20).
Understanding the specificity of mAbs that reactwith melanosomal antigens will
be important for sorting out the identity of these molecules. It has been proposed
in a recent report by Jimenez et al. (41) that a second gene only distantly related
to BBTY1 and Pmel 34 (33), mapping to the b (brown) locus in the mouse (42),
codes for a gene product with tyrosinase activity (41). Thus, it is becoming increas-
ingly evident that tyrosinase is a member of a family of related molecules that in-
clude distinct genes and alternative transcripts of these genes (32-34, 36, 41, 42).
Summary
Adistinguishing characteristic ofcells ofthe melanocyte lineage is the expression
of the melanosomal enzyme tyrosinase that catalyzes the synthesis of the pigment
melanin. A tyrosinase cDNA clone, designated BBTY1, was isolated from alibrary
constructed from the pigmented TA99+/CF21+ melanoma cell line SK-MEL-19. Ex-
pression of BBTY1 in mouse L929 fibroblasts led to synthesis and expression of
active tyrosinase, and, unexpectedly, to stable production of melanin. Melanin was
synthesized and stored within membrane-bound vesicles in the cytoplasm of trans-
fected fibroblasts. BBTY1 detected a 2.4-kb mRNA transcript in nine of nine pig-
mented, tyrosinase-positive melanoma cell lines. Tyrosinase transcripts of the same
size and abundance were detected in a subset (three ofeight) ofnonpigmented, tyros-
inase-negative melanoma cell lines, suggesting that post-transcriptional events are
important in regulating tyrosinase activity. Two melanocyte antigens, recognized
by mAbs TA99 and CF21, that are specifically located within melanosomes and are
coexpressed with tyrosinase activity, did notreactwith transfected mouse fibroblasts
expressing human tyrosinase, supporting the conclusion that these antigenic deter-
minants are distinct from the tyrosinase molecule coded for by BBTY1.2040
￿
EXPRESSION OF HUMAN TYROSINASE IN MOUSE FIBROBLASTS
We thankJeanie Melson for help in preparation ofthis manuscript, Peter Doskoch for tech-
nical assistance, Drs. Carlos Cordon-Cardo and Robert Erlandson for performing the EM
studies, and Drs. James P. DiSanto, Kenneth O. Lloyd, Joseph A. Trapani, and Hiroo Yuasa
for helpful discussions.
Receivedforpublication 21 December 1988 and in revisedform 23 February 1989.
References
1 . Kwon, B. S., A. K. Haq, S. H. Pomerantz, and R. Halaban. 1987. Isolation and se-
quence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.
Proc. Natl. Acad. Sci. USA. 84:7473.
2 . Houghton, A . N., M. Eisinger, A. P Albino, J . G. Cairncross, and L. J. Old. 1982.
Surface antigens of melanocytes and melanoma: markers of melanocyte differentiation
and melanoma subsets. J. Exp. Med. 156:1755.
3 . Kit, S., D. Dubbs, L. Piekarski, and T. Hsu. 1963. Deletion ofthymidine kinase activity
from L cells resistant to bromodeoxyuridine. Exp. Cell Res. 31:297.
4 . Maniatis, T., E. F. Frish, and J. Sambrook. 1982. Molecular Cloning: A Laboratory
Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 545 pp.
5 . Gubler, U., and B. J. Hoffman . 1983. A simple and very efficient method of generating
cDNA libraries. Gene (Amst.). 25:263.
6. Watson, C. J., and J. F. Jackson. 1985. Constructing and screening cDNA libraries in
X gt 10 and X gt 11. In DNA Cloning: A Practical Approach. D. M. Glover, editor. IRL
Press Limited, Oxford. 79-100.
7 . Huynh, T. V., R. A. Young, and R. W. Davis. 1985. An alternative procedure for the
synthesis of double stranded cDNA for cloning in phage and plasmid vectors. In DNA
Cloning: A Practical Approach. D. M. Glover, editor. IRL Press Limited, Oxford. 49-78.
8 . Vieira, J., and J. Messing. 1982. The pUC plasmids, and M13mp7-derived system for
insertion mutagenesis and sequencing with synthetic universal primers. Gene (Amst.).
19 :259.
9 . Henikoff, S. 1984. Unidirectional digestion with Exonuclease III creates targeted break-
points for DNA sequencing. Gene (Amst.). 28:351.
10 . Sanger, F., S. Nicklen, and A. Coulson. 1977. DNA sequencing with chain termination
inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463.
11 . Miller, J ., and R. N. Germain. 1986. Efficient cell surface expression of class II MHC
molecules in the absence of associated invariant chain. J. Exp. Med. 164:1478.
12 . Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silver-
stein, and R. Axel. 1979. Transformation ofmammalian cells with genes from procaryotes
and eucaryotes. Cell. 16:777 .
13 . Lemke, H., G. Hammerling, and U. Hammerling. 1979. Fine specificity analysis with
monoclonal antibodies of antigens controlled by the MHC QaJTI region in mice. Im-
munol. Rev. 47 :175.
14. Real, E X., A. N. Houghton, A. P Albino, C. Cordon-Cardo, M. Melamed, H. F. Oettgen,
and L. J. Old. 1985. Surface antigens ofmelanomas and melanocytes defined by mouse
monoclonal antibodies: specificity analysis and comparison ofantigen expression in cul-
tured cells and tissues. Cancer Res. 45:4401.
15 . Cairncross, J. G., J. M . Mattes, H. R. Beresford, A. P Albino, A. N. Houghton, K. O.
Lloyd, and L. J. Old. 1982. Cell surface antigens ofhuman astrocytoma defined by mouse
monoclonal antibodies: identification of astrocytoma subsets. Proc. Nall. Acad. Sci. USA.
79:5641.
16 . Thomson, T. M., F. X. Real, S. Murakami, C. Cordon-Cardo, L. J. Old, and A. N.
Houghton. 1988. Differentiation antigens of melanocytes and melanoma: analysis ofBOUCHARD ET AL.
￿
2041
melanosome and cell surface markers of human pigmented cells with monoclonal anti-
bodies. ,I Invest. Dermatol. 90:459.
17. Natali, P G., C. Appollonj, M. Cuomo, M. R. Nicotra, and P Giacomini. 1986. A melano-
cyte differentiation antigen recognized by a new murine monoclonal antibody mAb. J.
Invest. Dermatol. 87:392 .
18. Kantor, R. R. S., J. M. Mattes, K. O. Lloyd, L. J . Old, and A. P Albino. 1987. Bio-
chemical analysis of two cell surface glycoprotein complexes, very common antigen 1
and very common antigen 2. .J. Biol. Chem. 262:31.
19. Fuller, B. B., J. B. Lunsford, and D. S. Iman. 1987. Melanocyte-stimulating hormone
regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures. J. Biol. Chem.
262:4024.
20 . Houghton, A. N., F. X. Real, L.J. Davis, C. Cordon-Cardo, and L. J . Old. 1987. Pheno-
typic heterogeneity of melanoma: relation to the differentiation program of melanoma
cells. J. Exp. Med. 164:812.
21 . Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of
bacteriophage T4. Nature (Lond). 227:680.
22 . Pomerantz, S. H . 1969. L-Tyrosine-3, 5'-3H assay for tyrosinase development in skin of
newborn hamsters. Science (Wash. DC). 164:838.
23. Von Heijne, G. 1983. Patterns of amino acids near signal sequencing cleavage sites. Eur.
J. Biochem. 133:17.
24. Kyte, J., and R. Doolittle. 1982. A simple method for displaying the hydropathic character
of a protein. J Mol. Biol. 157:105 .
25. Wilkins, M., and P Stephenson. 1984. Role of the conserved AAU-AAA sequence from
AAUAAA point mutants prevent mRNA 3' end formation. Science (Wash. DC). 226:1045.
26. Oikawa, A., and M. Nakayasu. 1973 . Quantitative measurement ofmelanin as tyrosine
equivalents and as weight of purified melanin. Yale) Biol. Med. 46:500.
27. Mason, H . S. 1948. The chemistry of melanin. III. Mechanism of the oxidation of di-
hydroxyphenylalanine and tyrosinase. ,j. Biota Chem. 172 :83.
28. Pawelek, J., and A. B. Lerner. 1978. 5-6 dihydroxyindole is a melanin precursor showing
potent cytotoxiciy. Nature (Loud.). 276:627.
29. Pawelek, J., A. Korner, A. Bergstrom, andJ. Bologna. 1980. New regulators ofmelanin
biosynthesis and the autodestruction of melanoma cells. Nature (Lond). 186:617.
30 . Silvers, W. K. 1979. The Coat Colors of Mice: A Model for Mammalian Gene Action
and Interaction. Springer-Verlag, Berlin. 379 pp.
31 . Hearing, V. J., and M. Jimenez. 1989. Analysis ofmammalian pigmentation at the mo-
lecular level. Pigm. Cell Res. 2:75.
32 . Yamamoto, H., S. Takeuchi, T Kudo, K. Makino, A. Nakata, T Shinoda, and T Takeuchi.
1987. Cloning and sequencing of mouse tyrosinase cDNA. jpn. J Genet. 62:271.
33 . Shibahara, S., Y. Tomita, T Sakuhura, C. Nager, B. Chaudhuri, and R. Nuller. 1986.
Cloning and expression of cDNA encoding mouse tyrosinase. NucleicAcids Res. 14:2413 .
34 . Muller, G. S., E. Ruppert, E. Schmid, and G. Schutz. 1988. Functional analysis ofalter-
natively spliced tyrosinase gene transcripts. EMBO (Eur. Mol. Biol. Organ.),) 7 :2723.
35 . Kwon, B. S., M. Wakulchik, A. K. Haq, R. Halaban, and D. Kestler. 1988. Sequence
analysis of mouse tyrosinase cDNA and the effect of melanotropin on its gene expres-
sion. Biochem. Biophys. Res. Commun. 153 :1301.
36 . Ruppert, S., G. Muffler, B. Kwon, and G. Schutz. 1988. Multiple transcripts ofthe mouse
tyrosinase gene are generated by alternative splicing. EMBO (Eur. Mol. Biol. Organ.),).
7:2715.
37. Kwon, B. S., R. Halaban, G. S. Kim, L. Usack, S. Pomerantz, and A. K. Haq. 1987 .
A melanocyte-specific complementary cDNA clone whose expression is inducible by
melanotropin and isobutylmethyl xanthine. Mol. Biol. Med. 4:339.2042
￿
EXPRESSION OF HUMAN TYROSINASE IN MOUSE FIBROBLASTS
38. Tai, T., M. Eisinger, S. Ogata, and K. O. Lloyd. 1983. Glycoproteins as differentiation
markers in human malignant melanoma and melanocytes. Cancer Res. 43 :2773.
39. Mattes, J ., T. M. Thomson, L. J. Old, and K. O. Lloyd. 1983. A pigmentation-associated,
differentiation antigen ofhuman melanoma defined by a precipitating antibody in human
serum. Int. J. Cancer. 32:717.
40 . Thomson, T. M., J. Mattes, L. Roux, L. J. Old, and K. O. Lloyd. 1985. Pigmentation-
associated glycoprotein of human melanomas and melanocytes: definition with a mouse
monoclonal antibody. J. Invest. Dermatol. 85 :169.
41 . Jimenez, M., W. L. Maloy, and V. J . Hearing. 1989. Specific identification ofan authentic
clone for mammalian tyrosinase. J. Biol. Chem. 264:3397 .
42 . Jackson, I. T. 1988. A cDNA encoding tyrosinase-related protein maps to the brown locus
in mouse. Proc. Nad. Acad. Sci. USA. 85:4392.